Isthmus Partners’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-177,950
Closed -$8.66M 150
2022
Q1
$8.66M Buy
177,950
+8,448
+5% +$378K 1.42% 37
2021
Q4
$7.08M Buy
169,502
+4,749
+3% +$199K 1.19% 39
2021
Q3
$7.01M Buy
164,753
+8,208
+5% +$370K 1.27% 42
2021
Q2
$7.78M Buy
156,545
+172
+0.1% +$9.11K 1.37% 40
2021
Q1
$8.45M Buy
156,373
+39,667
+34% +$2.06M 1.55% 35
2020
Q4
$6.05M Buy
116,706
+1,682
+1% +$79.8K 1.23% 41
2020
Q3
$5.01M Buy
115,024
+938
+0.8% +$41.7K 1.17% 40
2020
Q2
$4.72M Buy
+114,086
New +$4.39M 1.16% 39
2015
Q2
Sell
-212
Closed -$10K 283
2015
Q1
$10K Sell
212
-22,555
-99% -$1.03M ﹤0.01% 240
2014
Q4
$928K Buy
+22,767
New +$806K 0.32% 48

Other funds holding CDK

Isthmus Partners's CDK Position: Q2 2022 in Review

Isthmus Partners sold out of CDK Global, Inc. (CDK) in Q2 2022, closing a stake of 177,950 shares — an estimated $8.66M sold.

Isthmus Partners first reported a position in CDK in Q4 2014 and held it in 10 quarters. The position peaked at $8.66M in Q1 2022. 456 funds tracked by Wall St. Rank hold CDK as of Q2 2022.

  • Isthmus Partners reported no remaining CDK Global, Inc. position as of Q2 2022 after selling out during the quarter.
  • Isthmus Partners sold 177,950 CDK Global, Inc. shares in Q2 2022, an estimated $8.66M.
  • Isthmus Partners first reported a position in CDK Global, Inc. in Q4 2014 and held it in 10 quarters.
  • Isthmus Partners's CDK Global, Inc. position peaked at $8.66M in Q1 2022.
  • 456 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2022.

Based on Isthmus Partners's 13F filing for Q2 2022, filed 8 Aug 2022.